SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

消費者向け遺伝子検査の世界市場と技術

Direct-to-Consumer Genetic Testing: Global Markets and Technologies

商品番号：SMB-68993
出版社BCC Research
出版年月2024年11月
ページ数84
価格タイプシングルユーザライセンス
価格USD 4,650
種別英文調査報告書

Report Highlights

The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.

Report Includes

  • 18 data tables and 27 additional tables
  • An overview of the global market and technologies for Direct-to-Consumer Genetic Testing
  • Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
  • Evaluation of the current market size and prospects for revenue growth, accompanied by a market share analysis by product type, and region
  • Forecast of future trends, including regulatory challenges, review of patents, ESG trends and emerging technologies
  • Market share analysis of the key companies in the industry and coverage of mergers & acquisitions, joint ventures, collaborations, partnerships and other strategies
  • Profiles of the major players, including Ancestry, 23andMe, MyHeritage, myDNA, Dante Labs, and Color Health

Report Scope

The report analyzes the market for DTC genetic testing, offering a look at the competitive landscape and the leading companies’ revenues, product portfolios and recent developments. The report analyzes trends and market dynamics, including drivers, limitations, challenges and opportunities. It assesses current and potential market size, in order to help industry executives make informed decisions about the production and licensing of goods and services. The study segments the market on the basis of segment/application type, such as ancestry, health and lifestyle. The health market segment is analyzed by technology and by disease category (cancer, cardiovascular, complex common, pharmacogenomics, rare diseases and others). The lifestyle market segment is segmented by technology and application (genetic relatedness, nutrigenomics, personal traits, weight management/fitness and others).

Regional market analysis is provided for all the major segments. The report covers tests that are directly ordered by consumers and consumer-initiated, physician-monitored tests. The DTC genetic testing of animals is outside the scope of the report. Regional market analysis is provided for all the major segments, and this includes some country-level analysis.

This report reviews the main DTC genetic testing technologies, including next-generation sequencing (NGS) and genotyping microarrays.

In this report, the market is divided into the following segments:

Market applications:

  • Ancestry.
  • Health.
  • Lifestyle.

Technologies:

  • Genotyping arrays.
  • Whole genome sequencing (WGS).
  • Whole exome sequencing (WES).
  • Polymerase chain reaction (PCR).
  • Targeted sequencing.

For each segment, current products are identified for the base year of 2023, the current market size is measured and market drivers identified, forecasts are made for 2029, and the current market shares of companies are assessed.

Report Synopsis

Report MetricsDetails
Base year considered2023
Forecast period considered2024-2029
Base year market size$2.1 billion
Market size forecast$3.7 billion
Growth rateCAGR of 10.0% for the forecast period of 2024-2029
Units considered$ Millions
Segments coveredProduct Type, and Region
Regions coveredNorth America, Europe, Asia-Pacific, Latin America, Rest of the World
Countries coveredU.S., Canada, Mexico, Germany, France, U.K., Spain, Italy, China, India, Japan, Brazil, Argentina, and Chile
Key Market Drivers
  • Increased access to genetic testing due to low cost of genomic sequencing.
  • Aggressive marketing.
  • Preference for pharmacogenomic testing based on DTC genetic testing.
  • Growing prevalence of chronic diseases, such as cancer and diabetes.
Companies studied
23ANDME INC.ANCESTRY
COLOR HEALTH INC.DANTE LABS GLOBAL
MYHERITAGE LTD.MYDNA LIFE AUSTRALIA PTY LTD.
PRIVAPATH DIAGNOSTICS

Table of Contents

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Market Overview and Definitions
Genetic Testing
History of DTC Genetic Testing
Types of DTC Genetic Tests
Regulatory Framework
United States
Europe
Asia-Pacific
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Dropping Cost of Genomic Sequencing
Aggressive Marketing
Pharmacogenomic Testing
Increasing Prevalence of Chronic Diseases
Increasing Awareness
Market Opportunities
Enhancing Patient-Physician Collaboration
Market Restraints
Inefficiencies of DTC Genetic Tests
Limited Insurance Coverage
Privacy Concerns
False Results
Costs of Increased Referrals
Market Challenges
Supply Chain Challenges
Data Management, Quality Control and Customer Service
Chapter 4 Emerging Technologies and Developments
Overview
Artificial Intelligence
WGS and WES
Blockchain Technology
Genomic Data in Drug Development
Chapter 5 DTC Genetic Testing Market
Segmentation Breakdown
Market Breakdown, by Product Type
Ancestry DTC Genetic Testing Market
Health DTC Genetic Testing Market
Lifestyle DTC Genetic Testing Market
Geographic Breakdown
Market Breakdown, by Region
North America
Europe
Asia-Pacific
Latin America
Rest of the World
Chapter 6 Competitive Intelligence
Industry Scenario
Company Shares
Competitive Landscape
Chapter 7 Sustainability in the DTC Genetic Testing Industry: An ESG Perspective
Introduction to ESG
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC
Chapter 8 Patent Analysis
Chapter 9 Appendix
Research Methodology
References
Abbreviations
Company Profiles
23ANDME INC.
ANCESTRY
COLOR HEALTH INC.
DANTE LABS GLOBAL
MYDNA LIFE AUSTRALIA PTY LTD.
MYHERITAGE LTD.
PRIVAPATH DIAGNOSTICS

List of Tables

List of Tables
Summary Table : Global DTC Genetic Testing Market, by Product Type, Through 2029
Table 1 : DTC Genetic Testing Types
Table 2 : Products from Selected DTC Genetic Testing Companies
Table 3 : DTC Genetic Testing Synonyms
Table 4 : FDA Regulatory Pathways for DTC Genetic Testing
Table 5 : DTC Genetic Tests with FDA Marketing Authorization
Table 6 : Cases of Diabetes, by Country, 2021
Table 7 : Global Incidence of All Cancers, by Region, Estimated and Projected, 2022-2045
Table 8 : Global DTC Genetic Testing Market, by Product Type, Through 2029
Table 9 : Global DTC Genetic Testing Market, by Technology, Through 2029
Table 10 : Global DTC Genetic Testing Market, by Delivery Format, Through 2029
Table 11 : Global Ancestry DTC Genetic Testing Market, by Technology, Through 2029
Table 12 : Global Health DTC Genetic Testing Market, by Disease Category, Through 2029
Table 13 : Global Health DTC Genetic Testing Market, by Technology, Through 2029
Table 14 : Global Lifestyle DTC Genetic Testing Market, by Application, Through 2029
Table 15 : Global Lifestyle DTC Genetic Testing Market, by Technology, Through 2029
Table 16 : Global DTC Genetic Testing Market, by Region, Through 2029
Table 17 : North American DTC Genetic Testing Market, by Country, Through 2029
Table 18 : European DTC Genetic Testing Market, by Country, Through 2029
Table 19 : Asia-Pacific DTC Genetic Testing Market, by Country, Through 2029
Table 20 : Latin American DTC Genetic Testing Market, by Country, Through 2029
Table 21 : RoW DTC Genetic Testing Market, Through 2029
Table 22 : ESG: Environmental Overview
Table 23 : ESG: Social Overview
Table 24 : ESG: Governance Overview
Table 25 : Patents Related to DTC Genetic Testing, January 2020 to September 2024
Table 26 : Abbreviations Used in This Report
Table 27 : 23andMe Inc.: Company Snapshot
Table 28 : 23andMe Inc.: Financial Performance, 2022 and 2023
Table 29 : 23andMe Inc.: Product Portfolio
Table 30 : 23andMe Inc.: News/Key Developments, 2023
Table 31 : Ancestry: Company Snapshot
Table 32 : Ancestry: Product Portfolio
Table 33 : Color Health Inc.: Company Snapshot
Table 34 : Color Health Inc.: Product Portfolio
Table 35 : Color Health Inc.: News/Key Developments, 2024
Table 36 : Dante Labs Global: Company Snapshot
Table 37 : Dante Labs Global: Product Portfolio
Table 38 : Dante Labs Global: News/Key Developments, 2023 and 2021
Table 39 : myDNA Life Australia Pty Ltd.: Company Snapshot
Table 40 : myDNA Life Australia Pty Ltd.: Product Portfolio
Table 41 : MyHeritage Ltd.: Company Snapshot
Table 42 : MyHeritage Ltd.: Product Portfolio
Table 43 : PrivaPath Diagnostics: Company Snapshot
Table 44 : PrivaPath Diagnostics: Product Portfolio

List of Figures

List of Figures
Summary Figure A : Global DTC Genetic Testing Market, by Product Type, 2021-2029
Summary Figure B : Global DTC Genetic Testing Market Shares, by Product Type, 2023
Figure 1 : Developments in DTC Genetic Testing Since the 1990s
Figure 2 : DTC Genetic Testing: Market Dynamics
Figure 3 : Share of All Cancer Cases Globally, by Region, 2022
Figure 4 : Emerging Technologies in DTC Genetic Testing
Figure 5 : Global DTC Genetic Testing Market Shares, by Product Type, 2023
Figure 6 : Global DTC Genetic Testing Market Shares, by Technology, 2023
Figure 7 : Global DTC Genetic Testing Market Shares, by Delivery Format, 2023
Figure 8 : Global Ancestry DTC Genetic Testing Market Shares, by Technology, 2023
Figure 9 : Global Health DTC Genetic Testing Market Shares, by Disease Category, 2023
Figure 10 : Global Health DTC Genetic Testing Market Shares, by Technology, 2023
Figure 11 : Global Lifestyle DTC Genetic Testing Market Shares, by Application, 2023
Figure 12 : Global Lifestyle DTC Genetic Testing Market Shares, by Technology, 2023
Figure 13 : Global DTC Genetic Testing Market Shares, by Region, 2023
Figure 14 : North American DTC Genetic Testing Market Shares, by Country, 2023
Figure 15 : European DTC Genetic Testing Market Shares, by Country, 2023
Figure 16 : Asia-Pacific DTC Genetic Testing Market Shares, by Country, 2023
Figure 17 : Latin American DTC Genetic Testing Market Shares, by Country, 2023
Figure 18 : Global Company Shares of DTC Genetic Testing Market, 2023
Figure 19 : ESG Pillars
Figure 20 : Advantages of ESG for Companies
Figure 21 : 23andMe Inc.: Revenue Shares, by Business Unit, 2023
Figure 22 : 23andMe Inc.: Revenue Shares, by Business Unit, 2023

医療・医薬の最新記事8件